April 28th, 2023
This conference has already taken place.
Description
The 2023 Cardio-Oncology Symposium addresses important clinical topics relevant to the cardiovascular health of patients with cancer. The symposium faculty will discuss new cancer treatments and strategies in diagnosis and management of cardiovascular disease in cancer patients from early diagnosis, treatment and long-term surveillance. It is anticipated that this CME activity will Improve care for cardio-oncology patients by understanding the short-term and delayed onset cardiotoxic effects of emerging cancer therapies. In addition, identifying when cardiovascular disease issues develop with cancer patient treatment strategies can be implemented more promptly. Case scenarios will be central to this educational activity.
REGISTRATION FOR THIS SYMPOSIUM IS CLOSED. FOR FURTHER INFORMATION ABOUT REGISTRATION COMMUNICATE WITH THE CONTACT LISTED BELOW.
All current registrants have been sent an email from Ellen Yokoyama with the login link for this symposium. If you cannot find that email or are experiencing issues accessing the symposium platform, please email virtual.support@bartha.com.
Dates and Times
Start: 4/28/2023 7:50 AM
End: 4/28/2023 4:15 PM
Objectives
At the conclusion of the continuing medical education activity participants should be able to:
1. Define the short-term and long-term cardiotoxic effects of contemporary cancer therapies.
2. Identify the best strategies to recognize when cardiovascular issues develop with your cancer patient.
3. Describe the role of cardioprotective therapy in your cancer patient population.
4. Compare cardiac imaging modalities to determine the optimal test for specific cancer patients.
5. Identify and integrate emerging cardio-oncology guidelines in clinical practice.
6. Recognize advancements and challenges in diagnosing and managing cardiac amyloidosis.
Agenda
Agenda
Moderators: Daniel Addison, MD and Bhuvaneswari Ramaswamy, MD, MRCP
Module 1
7:50 am Welcome and housekeeping remarks
Ayesha Hasan, MD and Raphael Pollock, MD, PhD
8:00 Managing Acute Coronary Syndromes in Cancer Patients
Dean Boudoulas, MD
8:15 Cardiac Ablation Therapy in Cancer Patients
Mahmoud Houmsse, MD
8:30 Cardiotoxicity after Cellular (CAR-T Cell) Therapies
Jonathan Brammer, MD
8:45 BTK inhibitor-induced Cardiac Arrhythmias
Adam Kittai, MD
9:00 Uses of STRAIN Imaging in Patients with Cancer
Adam Potter, MD
9:15 Addressing Cardiovascular Risk in Diverse Prostate Cancer Populations
Avirup Guha, MD, RPVI
9:30 Preventing and Managing Radiation associated CVD
Eric Miller, MD, PhD
9:45 Break
Module 2
10:00 Cardiovascular Toxicities of Immune Checkpoint Inhibitors
Ajay Vallakati, MBBS
10:15 Emerging Mechanisms of Tyrosine Kinase Inhibitor Cardiac Toxicity
Sakima Smith, MD, MPH
10:30 Managing Chronic CAD in the Cancer Patient
Richard Gumina, MD, PhD
10:45 Addressing Disparities in Cardio-Oncology Populations
Arnethea Sutton, PhD
11:00 Use of Advanced Cardiac Imaging in the Cancer Patient
Daniel Addison, MD
11:15 Managing Hypertension associated with Cancer Therapies
Jason Prosek, MD
11:30 Cardio-Oncology Needs from the Perspective of an Oncologist
Bhuvaneswari Ramaswamy, MD, MRCP
11:45 New Insights into the role of CHIP mutations and the Risk of Cardiovascular Disease
Uma Borate, MD, MS
12:00 pm LUNCH
Module 3
Breakout Sessions:
12:55 pm Welcome and housekeeping – Dr. Addison
Breakout A – Cardiac Complications of Cancer Immune Therapies – emerging role of Imaging
Avirup Guha, MD, MPH, Alma Habib, MD, Alexa Meara, MD, Paaladinesh Thavendiranathan, MD
1:00 Case Scenario (immune Checkpoint Myocarditis)
Alma Habib, MD
1:05 Case Scenario (CAR-T cell induced heart failure)
Alma Habib, MD
1:10 Panel Discussion
Avirup Guha, MD, Alma Habib, MD, Alexa Meara, MD, Paaladinesh Thavendiranathan, MD
1:30 Keynote Lecture: Cardiac Complications of Cancer Immune Therapy: The Role of Imaging
Paaladinesh Thavendiranathan, MD
Breakout B – Novel Cancer Targeted and Immune Therapy associated Cardiotoxicities
Daniel Addison, MD, Nausheen Akhter, MD, Jonathan Brammer, MD, Benjamin Buck, MD, and Mahmoud Houmsse, MD
2:00 Case Scenarios (BTKI associated Atrial Fibrillation)
Benjamin Buck, MD
2:05 Case Scenarios (Stem cell transplant associated heart failure)
Benjamin Buck, MD
2:10 Panel Discussion:
Daniel Addison, MD, Nausheen Akhter, MD, Jonathan Brammer, MD, Benjamin Buck, MD, and Mahmoud Houmsse, MD
2:30 Keynote Lecture: Novel Targeted Therapy associated cardiotoxicities- how do we screen and management these events?
Nausheen Akhter, MD
3:00 Break
Breakout C – Cardiac Amyloidosis in the 21st Century
Zachary Braunstein, MD, Naresh Bumma, MD, Courtney Campbell, MD PhD, and, Ajay Vallakati, MBBS
3:15 Case Scenarios (Indeterminate PYP Imaging, and course of care)
Zachary Braunstein, MD
3:20 Case Scenarios (CHF in Myeloma, and Orthopedic associations)
Zachary Braunstein, MD
3:25 Panel Discussion:
Naresh Bumma, MD, Courtney Campbell, MD, PhD
3:45 Keynote: New Directions in Cardiac Amyloidosis Treatment
Ajay Vallakati, MBBS
4:15 Meeting Adjournment
Daniel Addison, MD
Pricing
| Tier | Price |
|---|---|
| Physician, attending in person | $0.00 |
| Nurse/Nurse Practitioner, attending in person | $0.00 |
| Allied Medical Professional, attending in person | $0.00 |
| Other, attending in person | $0.00 |
| Physician. participating online | $0.00 |
| Nurse/Nurse Practitioner, participating online | $0.00 |
| Allied Health Professional, participating online | $0.00 |
| Other, participating online | $0.00 |
Speakers
Location
The Ohio State University Medical Center
Biological Research Tower
460 W. 12th Avenue
Columbus, OH 43210
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.